関連する実験動画
Updated: Feb 23, 2026

07:20
Exploring the Regulation of Lipid Droplet Catabolism through Lipophagy
Published on: January 31, 2025
1.3K
カドミウムによって誘発されたATP6V0A1の不安定化は,リンソソームの機能を低下させ,肝臓の脂質ホメオスタシスを破壊する
Juan Huo1, Kongdong Li2, Haifeng Shi2
1Department of Central Laboratory, the First People's Hospital of Lianyungang, Lianyungang, Jiangsu, 222002, China.
Biochimica et biophysica acta. Molecular and cell biology of lipids
|February 21, 2026
まとめ
慢性的なカドミウム曝露は,ATP6V0A1タンパク質を分解し,リソソーム機能を低下させ,オートファギーを阻害することにより,高トリグリセリデミアを引き起こす. ATP6V0A1レベルを回復することで,脂質代謝を正常化し,カドミウム誘発性脂肪肝疾患を治療することができます.
科学分野:
- 環境毒理学 環境毒理学
- 細胞生物学 細胞生物学
- メタボリック疾患
背景:
- 慢性的なカドミウム (Cd2+) 曝露は,高トリグリセリデミアおよび代謝障害に関連しています.
- カドミウムによって引き起こされる肝臓の脂質代謝障害の背後にあるメカニズムは不明である.
- リソソーム機能とオートファギーは,脂質分解に不可欠であり,カドミウム毒性の潜在的な標的である.
研究 の 目的:
- 肝臓の脂質代謝に対するカドミウム曝露の影響を調査する.
- カドミウム誘発ステアトーシスにおけるV-ATPaseサブユニットであるATP6V0A1の役割を明らかにする.
- カドミウム関連脂肪肝疾患の潜在的な治療標的を特定する.
主な方法:
- 多株マウスモデルとヒト肝細胞を用いた.
- 血清代謝学,生化学的測定,およびリソソームのpHを測定した.
- 遺伝的アプローチ (ノックダウン/過剰発現),オートファジックフルスアッセイ,タンパク質の安定性測定を用いた.
主要な成果:
- カドミウムへの曝露はハイパートリグリセリデミアを誘発し,マウスの血清脂質プロフィールを変化させた.
- カドミウムは肝臓のATP6V0A1タンパク質をダウン調節し,リソソーム酸性化が低下し,自死流が阻害された.
- カドミウムはATP6V0A1のタンパク質の分解を促進し,ATP6V0A1の過剰発現によって救われました.
結論:
- カドミウム曝露は,ATP6V0A1を転写後の不安定化させ,リソソーム機能障害とオートファジックブロックを引き起こします.
- この経路は肝臓のトリグリセリドの蓄積を促し,脂肪肝疾患に寄与する.
- ATP6V0A1はカドミウム誘発代謝障害の重要な調節体であり,潜在的な治療標的である.
関連する概念動画
Lysosomal Hydrolases
4.7K
Lysosomes are the site for the degradation of macromolecules and biological polymers released during membrane trafficking events such as secretory, endocytic, autophagic, and phagocytic pathways. The membrane-enclosed area of the lysosome, called the lumen, contains hydrolytic enzymes active in an acidic environment. These acid hydrolases are functional at a pH between 4.5 and 5 and are involved in cellular processes such as cell signaling, energy metabolism, restoration of the plasma membrane,...
4.7K
Allosteric Proteins-ATCase
6.7K
Binding sites linkages can regulate a protein's function. For example, enzyme activity is often regulated through a feedback mechanism where the end product of the biochemical process serves as an inhibitor.
Aspartate transcarbamoylase (ATCase) is a cytosolic enzyme that catalyzes the condensation of L-aspartate and carbamoyl phosphate to N-carbamoyl-L-aspartate. This reaction is the first step in pyrimidine biosynthesis. UTP and CTP, the end products of the pyrimidine synthesis...
Aspartate transcarbamoylase (ATCase) is a cytosolic enzyme that catalyzes the condensation of L-aspartate and carbamoyl phosphate to N-carbamoyl-L-aspartate. This reaction is the first step in pyrimidine biosynthesis. UTP and CTP, the end products of the pyrimidine synthesis...
6.7K
Lipid Catabolism
1.2K
Triglycerides serve as crucial long-term energy storage molecules in microorganisms, providing a dense source of metabolic energy. Their breakdown is mediated by lipases, which hydrolyze triglycerides into glycerol and free fatty acids. Each of these components follows distinct metabolic pathways, ultimately contributing to ATP synthesis and cellular energy homeostasis.Glycerol MetabolismGlycerol, released from triglyceride hydrolysis, is phosphorylated by glycerol kinase to form...
1.2K
Export of Misfolded Proteins out of the ER
5.3K
After folding, the ER assesses the quality of secretory and membrane proteins. The correctly folded proteins are cleared by the calnexin cycle for transport to their final destination, while misfolded proteins are held back in the ER lumen. The ER chaperones attempt to unfold and refold the misfolded proteins but sometimes fail to achieve the correct native conformation. Such terminally misfolded proteins are then exported to the cytosol by ER-associated degradation or ERAD pathway for...
5.3K

